A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients with Myotonic Dystrophy Type 1, Followed by an Open-Label Extension

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

UCHealth Central Park Medical Center
University of Colorado Hospital

Principal Investigator
Photograph of Matthew Wicklund,  MD

Matthew Wicklund, MD

Study ID

Protocol Number: 21-3397

More information available at ClinicalTrials.gov: NCT04886518

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers